S&P 500   4,236.47 (-1.21%)
DOW   33,069.68 (-1.09%)
QQQ   355.63 (-1.56%)
AAPL   171.96 (-1.03%)
MSFT   313.50 (-2.58%)
META   300.53 (-2.05%)
GOOGL   132.77 (-1.04%)
AMZN   125.37 (-3.16%)
TSLA   248.69 (-1.16%)
NVDA   438.50 (-2.08%)
NIO   8.70 (-1.02%)
BABA   84.79 (-2.01%)
AMD   100.69 (-2.50%)
T   14.60 (-0.48%)
F   12.13 (-1.46%)
MU   68.44 (+0.71%)
CGC   0.70 (-5.17%)
GE   107.77 (-0.94%)
DIS   79.86 (-2.22%)
AMC   8.00 (-1.84%)
PFE   33.88 (-0.18%)
PYPL   57.70 (-1.47%)
NFLX   378.36 (-0.52%)
S&P 500   4,236.47 (-1.21%)
DOW   33,069.68 (-1.09%)
QQQ   355.63 (-1.56%)
AAPL   171.96 (-1.03%)
MSFT   313.50 (-2.58%)
META   300.53 (-2.05%)
GOOGL   132.77 (-1.04%)
AMZN   125.37 (-3.16%)
TSLA   248.69 (-1.16%)
NVDA   438.50 (-2.08%)
NIO   8.70 (-1.02%)
BABA   84.79 (-2.01%)
AMD   100.69 (-2.50%)
T   14.60 (-0.48%)
F   12.13 (-1.46%)
MU   68.44 (+0.71%)
CGC   0.70 (-5.17%)
GE   107.77 (-0.94%)
DIS   79.86 (-2.22%)
AMC   8.00 (-1.84%)
PFE   33.88 (-0.18%)
PYPL   57.70 (-1.47%)
NFLX   378.36 (-0.52%)
S&P 500   4,236.47 (-1.21%)
DOW   33,069.68 (-1.09%)
QQQ   355.63 (-1.56%)
AAPL   171.96 (-1.03%)
MSFT   313.50 (-2.58%)
META   300.53 (-2.05%)
GOOGL   132.77 (-1.04%)
AMZN   125.37 (-3.16%)
TSLA   248.69 (-1.16%)
NVDA   438.50 (-2.08%)
NIO   8.70 (-1.02%)
BABA   84.79 (-2.01%)
AMD   100.69 (-2.50%)
T   14.60 (-0.48%)
F   12.13 (-1.46%)
MU   68.44 (+0.71%)
CGC   0.70 (-5.17%)
GE   107.77 (-0.94%)
DIS   79.86 (-2.22%)
AMC   8.00 (-1.84%)
PFE   33.88 (-0.18%)
PYPL   57.70 (-1.47%)
NFLX   378.36 (-0.52%)
S&P 500   4,236.47 (-1.21%)
DOW   33,069.68 (-1.09%)
QQQ   355.63 (-1.56%)
AAPL   171.96 (-1.03%)
MSFT   313.50 (-2.58%)
META   300.53 (-2.05%)
GOOGL   132.77 (-1.04%)
AMZN   125.37 (-3.16%)
TSLA   248.69 (-1.16%)
NVDA   438.50 (-2.08%)
NIO   8.70 (-1.02%)
BABA   84.79 (-2.01%)
AMD   100.69 (-2.50%)
T   14.60 (-0.48%)
F   12.13 (-1.46%)
MU   68.44 (+0.71%)
CGC   0.70 (-5.17%)
GE   107.77 (-0.94%)
DIS   79.86 (-2.22%)
AMC   8.00 (-1.84%)
PFE   33.88 (-0.18%)
PYPL   57.70 (-1.47%)
NFLX   378.36 (-0.52%)
NASDAQ:XAIR

Beyond Air (XAIR) Stock Forecast, Price & News

$2.11
-0.02 (-0.94%)
(As of 12:18 PM ET)
Compare
Today's Range
$2.06
$2.16
50-Day Range
$2.13
$3.66
52-Week Range
$2.06
$8.06
Volume
127,354 shs
Average Volume
402,806 shs
Market Capitalization
$66.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.25

Beyond Air MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
475.1% Upside
$12.25 Price Target
Short Interest
Bearish
9.65% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.91
Upright™ Environmental Score
News Sentiment
-0.27mentions of Beyond Air in the last 14 days
Based on 3 Articles This Week
Insider Trading
Acquiring Shares
$915,579 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($1.88) to ($1.69) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.97 out of 5 stars

Medical Sector

586th out of 975 stocks

Surgical & Medical Instruments Industry

65th out of 100 stocks


XAIR stock logo

About Beyond Air (NASDAQ:XAIR) Stock

Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.

XAIR Price History

XAIR Stock News Headlines

Is Gold Really Boring?
Many investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks.
Beyond Air Insiders Placed Bullish Bets Worth US$2.3m
Beyond Air (NASDAQ: XAIR)
Is Gold Really Boring?
Many investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks.
Director of Beyond Air Purchased $243K In Stock
Recap: Beyond Air Q4 Earnings
See More Headlines
Receive XAIR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Beyond Air and its competitors with MarketBeat's FREE daily newsletter.

XAIR Company Calendar

Last Earnings
8/10/2023
Today
10/03/2023
Next Earnings (Estimated)
11/14/2023
Fiscal Year End
3/31/2024

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:XAIR
Fax
N/A
Employees
98
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$12.25
High Stock Price Forecast
$15.00
Low Stock Price Forecast
$10.00
Forecasted Upside/Downside
+475.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$-55,820,000.00
Pretax Margin
-106,444.07%

Debt

Sales & Book Value

Annual Sales
$870,000.00
Book Value
$1.40 per share

Miscellaneous

Free Float
26,770,000
Market Cap
$67.54 million
Optionable
Not Optionable
Beta
-0.28
The Best High-Yield Dividend Stocks for 2023 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Mr. Steven Adam LisiMr. Steven Adam Lisi (Age 52)
    CEO & Chairman
    Comp: $650k
  • Mr. Amir  AvnielMr. Amir Avniel (Age 49)
    Pres, Chief Bus. Officer & Director
    Comp: $400k
  • Mr. Michael A. Gaul (Age 68)
    Chief Operating Officer
    Comp: $350k
  • Mr. Douglas Quinton Larson (Age 52)
    CFO, Principal Financial Officer & Principal Accounting Officer
  • Edward Barger
    Head of Investor Relations
  • Ms. Rebecca Van Doren
    Head of Sales
  • Ms. Kori-Ann Taylor
    Head of Marketing
  • Dr. Andrew R. Colin M.D.
    Sr. Medical Director Global Clinical Leadership & Member of Scientific Advisory Board
  • Mr. Duncan Fatkin
    Chief Commercial Officer
  • Dr. Jeff Myers M.D. (Age 58)
    Ph.D., Chief Medical Officer













XAIR Stock - Frequently Asked Questions

Should I buy or sell Beyond Air stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Beyond Air in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" XAIR shares.
View XAIR analyst ratings
or view top-rated stocks.

What is Beyond Air's stock price forecast for 2023?

3 brokerages have issued twelve-month price objectives for Beyond Air's shares. Their XAIR share price forecasts range from $10.00 to $15.00. On average, they predict the company's share price to reach $12.25 in the next twelve months. This suggests a possible upside of 475.1% from the stock's current price.
View analysts price targets for XAIR
or view top-rated stocks among Wall Street analysts.

How have XAIR shares performed in 2023?

Beyond Air's stock was trading at $6.49 at the start of the year. Since then, XAIR stock has decreased by 67.2% and is now trading at $2.13.
View the best growth stocks for 2023 here
.

When is Beyond Air's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 14th 2023.
View our XAIR earnings forecast
.

How were Beyond Air's earnings last quarter?

Beyond Air, Inc. (NASDAQ:XAIR) posted its quarterly earnings results on Thursday, August, 10th. The company reported ($0.45) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.46) by $0.01. The firm earned $0.06 million during the quarter, compared to analysts' expectations of $0.20 million.

What other stocks do shareholders of Beyond Air own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Beyond Air investors own include OPKO Health (OPK), NVIDIA (NVDA), Pfizer (PFE), Axsome Therapeutics (AXSM), BioCryst Pharmaceuticals (BCRX), Enphase Energy (ENPH), General Motors (GM), Livongo Health (LVGO), Main Street Capital (MAIN) and Ollie's Bargain Outlet (OLLI).

What is Beyond Air's stock symbol?

Beyond Air trades on the NASDAQ under the ticker symbol "XAIR."

How do I buy shares of Beyond Air?

Shares of XAIR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Beyond Air's stock price today?

One share of XAIR stock can currently be purchased for approximately $2.13.

How much money does Beyond Air make?

Beyond Air (NASDAQ:XAIR) has a market capitalization of $67.54 million and generates $870,000.00 in revenue each year. The company earns $-55,820,000.00 in net income (profit) each year or ($1.95) on an earnings per share basis.

How can I contact Beyond Air?

Beyond Air's mailing address is 825 EAST GATE BOULEVARD SUITE 320, GARDEN CITY NY, 11530. The official website for the company is www.beyondair.net. The company can be reached via phone at (516) 665-8200.

This page (NASDAQ:XAIR) was last updated on 10/3/2023 by MarketBeat.com Staff

My Account -